Össur hf: New R&D Leadership - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Össur hf: New R&D Leadership

Announcement no. 25/2022

20 April 2022

New R&D Leadership

Dr. Kristleifur Kristjánsson, Executive Vice President of Research and Development, has decided to retire from 1 July 2022 after a decade with Össur. Hildur Einarsdóttir has been appointed Executive Vice President of Research and Development and will become a member of the Össur Executive Committee. Mrs. Einarsdóttir has been with Össur in various roles since 2009. She is an Electrical Engineer from the University of Iceland and holds a Master’s degree in Biomedical Engineering with focus on Computational Neuroscience from Imperial College London.

“Hildur Einarsdóttir has been a valuable leader within Össur R&D and Global Marketing during her 13 years with the Company. She has a proven track record of strategy execution and leading global teams. Her industry knowledge and passion for innovation will further advance Össur’s technological leadership and we look forward to having her join our Executive Committee. On behalf of everyone at Össur, we thank Kristleifur Kristjánsson for his valuable contribution to our Company over the years and wish him all the best in his retirement”, said Sveinn Sölvason, Össur President and CEO.

Further information

Edda Lára Lúðvígsdóttir, Investor Relations Director, [email protected], +354 844 4759

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors

About Össur

Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized “Technology Pioneer” with a rich 50-year history, Össur focuses on improving people’s mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women’s Empowerment Principles, contributes to the UN Sustainable Development Goals and became Carbon Neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com

Bifogade filer

Nyheter om Embla Medical

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Embla Medical

Senaste nytt